Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meg J Spriggs

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Scientific Reports|January 29, 2025
From relaxed beliefs under psychedelics (REBUS) to revised beliefs after psychedelics (REBAS)Richard J Zeifman, Meg J Spriggs, Hannes Kettner, et al.
Frontiers in Psychology|June 23, 2025
Enhanced meaning in life following psychedelic use: converging evidence from controlled and naturalistic studiesWilliam Roseby, Hannes Kettner, Leor Roseman, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 9, 2020
Ketamine improves short-term plasticity in depression by enhancing sensitivity to prediction errorsRachael L Sumner, Rebecca McMillan, Meg J Spriggs, et al.
Psychedelic Medicine (New Rochelle, N.Y.)|June 20, 2023
A Bayesian Reanalysis of a Trial of Psilocybin versus Escitalopram for DepressionSandeep M Nayak, Bilal A Bari, David B Yaden, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|September 10, 2019
Ketamine Enhances Visual Sensory Evoked Potential Long-term Potentiation in Patients With Major Depressive DisorderRachael L Sumner, Rebecca McMillan, Meg J Spriggs, et al.
Journal of Psychopharmacology (Oxford, England)|November 14, 2022
Body mass index (BMI) does not predict responses to psilocybinMeg J Spriggs, Bruna Giribaldi, Taylor Lyons, et al.
Journal of Psychopharmacology (Oxford, England)|March 30, 2021
A qualitative and quantitative account of patient's experiences of ketamine and its antidepressant propertiesRachael L Sumner, Emme Chacko, Rebecca McMillan, et al.
Frontiers in Psychiatry|November 8, 2021
Study Protocol for "Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study"Meg J Spriggs, Hannah M Douglass, Rebecca J Park, et al.
Scientific Reports|December 3, 2021
Spatial variation of perfusion MRI reflects cognitive decline in mild cognitive impairment and early dementiaCatherine A Morgan, Tracy R Melzer, Reece P Roberts, et al.
Frontiers in Human Neuroscience|March 5, 2019
Human Sensory LTP Predicts Memory Performance and Is Modulated by the <i>BDNF</i> Val<sup>66</sup>Met PolymorphismMeg J Spriggs, Chris S Thompson, David Moreau, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Scientific Reports|January 29, 2025
From relaxed beliefs under psychedelics (REBUS) to revised beliefs after psychedelics (REBAS)Richard J Zeifman, Meg J Spriggs, Hannes Kettner, et al.
Frontiers in Psychology|June 23, 2025
Enhanced meaning in life following psychedelic use: converging evidence from controlled and naturalistic studiesWilliam Roseby, Hannes Kettner, Leor Roseman, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 9, 2020
Ketamine improves short-term plasticity in depression by enhancing sensitivity to prediction errorsRachael L Sumner, Rebecca McMillan, Meg J Spriggs, et al.
Psychedelic Medicine (New Rochelle, N.Y.)|June 20, 2023
A Bayesian Reanalysis of a Trial of Psilocybin versus Escitalopram for DepressionSandeep M Nayak, Bilal A Bari, David B Yaden, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|September 10, 2019
Ketamine Enhances Visual Sensory Evoked Potential Long-term Potentiation in Patients With Major Depressive DisorderRachael L Sumner, Rebecca McMillan, Meg J Spriggs, et al.
Journal of Psychopharmacology (Oxford, England)|November 14, 2022
Body mass index (BMI) does not predict responses to psilocybinMeg J Spriggs, Bruna Giribaldi, Taylor Lyons, et al.
Journal of Psychopharmacology (Oxford, England)|March 30, 2021
A qualitative and quantitative account of patient's experiences of ketamine and its antidepressant propertiesRachael L Sumner, Emme Chacko, Rebecca McMillan, et al.
Frontiers in Psychiatry|November 8, 2021
Study Protocol for "Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study"Meg J Spriggs, Hannah M Douglass, Rebecca J Park, et al.
Scientific Reports|December 3, 2021
Spatial variation of perfusion MRI reflects cognitive decline in mild cognitive impairment and early dementiaCatherine A Morgan, Tracy R Melzer, Reece P Roberts, et al.
Frontiers in Human Neuroscience|March 5, 2019
Human Sensory LTP Predicts Memory Performance and Is Modulated by the <i>BDNF</i> Val<sup>66</sup>Met PolymorphismMeg J Spriggs, Chris S Thompson, David Moreau, et al.
Pageof 3